Heart Transplantation in Patients With Systemic Sclerosis
HT in SSc patients demonstrates good mid-term graft function despite an increased incidence of rejection, supporting feasibility in carefully selected candidates.
Authors
- M. Regan
- B. Elad (ORCID: https://orcid.org/0000-0001-9253-2351)
- Miroslav Sekulic (ORCID: https://orcid.org/0000-0002-7938-1816)
- I. Sobol
- F. Z. Ab. Latif
- Kyung Taek Oh (ORCID: https://orcid.org/0000-0002-4379-7238)
- D. Lotan
- Ilan Richter (ORCID: https://orcid.org/0000-0001-9358-0056)
- E. Horn
- Morgan Smith
- Adi Hertz (ORCID: https://orcid.org/0009-0004-3945-666X)
- Gabriel T. Sayer
- Ersilia M. DeFilippis
- Kevin Clerkin
- Nir Uriel
- Jayant Raikhelkar (ORCID: https://orcid.org/0000-0002-8561-7899)
- Julia Baranowska
Institutions
- NewYork–Presbyterian Hospital (US)
- Cornell University (US)
- Columbia University Irving Medical Center (US)
- Presbyterian Hospital (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1111/ctr.70424
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00